Connect with us


Shkreli Net Worth




In 2015, Martin Shkreli was named the “most hated man in America” by Time Magazine. This came after he raised the price of a life-saving drug by 5,000%. Despite his reputation, or perhaps because of it, Shkreli has an estimated net worth of $27.6 million.

The majority of his wealth comes from his time as CEO of Turing Pharmaceuticals. He is also the founder of two hedge funds, MSMB Capital Management and MSMB Healthcare.

In 2015, Martin Shkreli’s net worth was estimated to be $45 million. However, after his arrest on securities fraud charges in December of that year, his net worth is now believed to be closer to $5 million. Despite his legal troubles, Shkreli remains a polarizing figure in the business world, and his story continues to captivate the public.

Shkreli Net Worth 2022

Martin Shkreli is an American businessman, pharmaceutical executive, and investor. He is the co-founder and former CEO of Retrophin, a biopharmaceutical company, and founder of Turing Pharmaceuticals. In September 2015, Shkreli was indicted on federal charges of securities fraud and wire fraud.

In December 2015, he was arrested by the FBI on those charges. On March 14, 2018, he was convicted of two counts of securities fraud and one count of conspiracy to commit securities fraud. Shkreli’s first business venture was a health food store called Elite Health Center which he started at age 16 in Brooklyn.

He later started a hedge fund called MSMB Capital Management with his partner Joel Wittenberg; the fund made $1 billion in profits from 2011 to 2012 but then lost all its money in 2013 when it invested heavily in Biogen Idec Inc.’s unsuccessful attempt to buy Celgene Corporation. In February 2014, Shkreli founded Turing Pharmaceuticals and became its CEO; that year he increased the price of Daraprim (pyrimethamine), a drug used to treat toxoplasmosis in AIDS patients, from $13.50 per tablet to $750 per tablet – an increase of 5500%. This price hike caused widespread public outrageand led to multiple investigations into his business practices; some have accused himof attempting to profiteer off sick people.

In September 2015, Shkreli was indicted on federal charges of securities fraud related to his management of two hedge funds; he has pleaded not guilty and faces up to 20 years in prison if convicted.

Shkreli Net Worth


What is Martin Shkreli Iq?

Martin Shkreli IQ is estimated to be around 145. This is considered to be a high IQ and places him in the top 2% of the population. He has been able to use his high intelligence to become a successful entrepreneur.

He is the co-founder of several companies, including MSMB Capital Management, Retrophin, and Turing Pharmaceuticals. He has also been able to make a name for himself in the media and has become somewhat of a controversial figure.

How Many Years Did Martin Shkreli Get?

Martin Shkreli, the former CEO of Turing Pharmaceuticals, was sentenced to seven years in prison on Friday for defrauding investors. Shkreli was convicted last year of two counts of securities fraud and one count of conspiracy to commit securities fraud. Prosecutors said he misled investors about the performance of two hedge funds he ran, MSMB Capital and MSMB Healthcare, and later looted a drug company he founded, Retrophin, to pay them back.

“The real harm in this case was not the money that Martin Shkreli stole but the damage that his lies caused to so many people,” said U.S. District Judge Kiyo Matsumoto before imposing the sentence. “He cheated innocent investors out of their hard-earned savings.” Shkreli’s lawyers had asked Matsumoto to give him a sentence of 18 months or less, saying he has been demonized in the press and is not likely to reoffend.

They also noted that none of his investors lost money on their investments. But prosecutors argued that Shkreli deserved a lengthy prison term because his crimes were motivated by “greed and an unquenchable thirst for power.” They also said he showed no remorse for his actions and has continued to lie even after being convicted.


What Does Martin Shkreli Do Now?

Martin Shkreli has been in the news a lot lately for his involvement with pharmaceutical companies and their pricing practices. He is currently the CEO of Turing Pharmaceuticals, and he caused quite a stir when he raised the price of a lifesaving drug by 5,000%. Now, it seems that Shkreli is back in the news for allegedly trying to manipulate the stock market.

He has been accused of securities fraud and faces up to 20 years in prison if convicted.

Where is Martin Shkreli and what is his net worth?


Martin Shkreli, the former CEO of Turing Pharmaceuticals, has an estimated net worth of $27.6 million. That number could go up or down depending on the outcome of his fraud trial, however. Shkreli was arrested in 2015 and charged with securities fraud.

He is currently out on bail and awaiting trial. If convicted, he faces up to 20 years in prison.

Continue Reading